Showing results (141-150 of 421) with videos related to

Sort By:
Pageof 43
The Prostate|May 29, 2009
Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention TrialJeannette M Schenk, Alan R Kristal, Marian L Neuhouser, et al.
The Journal of Urology|August 12, 2005
Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trialRuth D Etzioni, Nadia Howlader, Pamela A Shaw, et al.
American Journal of Epidemiology|July 2, 2013
Should modest elevations in prostate-specific antigen, International Prostate Symptom Score, or their rates of increase over time be used as surrogate measures of incident benign prostatic hyperplasia?Jeannette M Schenk, Rachel Hunter-Merrill, Yingye Zheng, et al.
American Journal of Epidemiology|February 12, 2008
Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trialAlan R Kristal, Kathryn B Arnold, Jeannette M Schenk, et al.
Medical Hypotheses|August 6, 2018
mTOR inhibitors for treatment of low-risk prostate cancerMichael A Liss, Lanette Rickborn, John DiGiovanni, et al.
American Journal of Epidemiology|July 5, 2012
Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trialJeannette M Schenk, Gregory S Calip, Catherine M Tangen, et al.
The Prostate|February 26, 2023
Prevalence of genotoxic bacteria in men undergoing biopsy for prostate cancerJohn Lee, Brian L Wickes, Jianmin Fu, et al.
The Journal of Urology|June 14, 2008
[-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation studyLori J Sokoll, Yinghui Wang, Ziding Feng, et al.
The Journal of Urology|June 14, 2008
The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsyIan M Thompson, Catherine M Tangen, Donna P Ankerst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African AmericansStacie J Shook, Joke Beuten, Kathleen C Torkko, et al.
Pageof 43